Company-wide revenue
Reported revenue in 2020 ¥51.27B Reported revenue in 2024 ¥64.72B
- growth amount
- +¥13.45B
- growth annualized
- +6.0%
- growth total
- +26.2%
Japanese company profile · 4928
In its FY2024 public filing, noevir holdings co.,ltd. reports Cosmetics Business, Pharmaceuticals and foodstuffs. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: 株式会社ノエビアホールディングス
English company name recorded in Japan's EDINET filer data. English company name source
What does this company do?
noevir holdings co.,ltd.'s largest reported business by revenue in FY2024 was Cosmetics Business.
The business with the highest reported segment profit in FY2024 was Cosmetics Business.
FY2024 · fiscal year ended September 2025 View original filing ↗ The source document may be in Japanese.
Business structure
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Cosmetics Business | ¥50.52B ↗ | 78.1% | ¥12.29B ↗ |
| Pharmaceuticals and foodstuffs | ¥11.54B ↗ | 17.8% | ¥980M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2024 · fiscal year ended September 2025. Revenue and profit are shown only where the filing and data support a comparison.
Reported Sales by business over time
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Cosmetics Business | ¥38.33B | ¥47.03B | ¥48.17B | ¥49.76B | ¥50.52B |
| Pharmaceuticals and foodstuffs | ¥11.12B | ¥11.41B | ¥11.98B | ¥11.44B | ¥11.54B |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
Reported revenue in 2020 ¥51.27B Reported revenue in 2024 ¥64.72B
Reported revenue in 2020 ¥38.33B Reported revenue in 2024 ¥50.52B
Reported profit margin in 2021 +23.0%
Reported profit margin in 2024 +24.3%
This describes a reported period; it is not a forecast.
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
FY2024 · fiscal year ended September 2025
The source document may be in Japanese.
Filing ID: S100X8TQ
View original filing ↗Ask about this company
The source document may be in Japanese.